Form 4 for ENSC Ensysce Biosciences, Inc.
Accepted 2022-05-27 00:00:00 ET · period of report 2022-05-25 · accession 0001493152-22-015294 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-05-27 | 2022-05-25+ | ENSC | Kirkpatrick Lynn | CEO, Dir | P - Purchase | $0.5011 | +97.0K | 354.9K | +38% | +$48.6K |
| D | 2022-05-27 | 2022-02-17 | ENSC | Kirkpatrick Lynn | CEO, Dir | A - Grant | — | +200.0K | 2.52M | +9% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-26 | P | A | 27,000 | $0.53 | 381,851 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-25 | P | A | 70,000 | $0.49 | 354,851 | D | — | — | |
| 3 | Derivative | Stock Option | 2022-02-17 | A | A | 200,000 | — | 2,516,939 | D | $1.40 · — to 2032-02-17 | 200,000 Common Stock | (F1) On February 17, 2022, Dr. Kirkpatrick was granted an option (the "Stock Option") to purchase 200,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.0001 per share, with an exercise price of $1.40. The Stock Option is scheduled to vest over four years with 1/4 vesting upon the one year anniversary of February 17, 2022 and the remainder in equal installments monthly for the thirty-six months thereafter. The Form 4 filed February 24, 2022 included this same information for Table II except for the entry under column 9. |